Related Experiment Videos
Endogenous subclinical hyperthyroidism and cardiovascular system: time to reconsider?
International Journal of Cardiology
|May 29, 2009
Summary
Subclinical hyperthyroidism, a condition with low thyroid-stimulating hormone, requires prompt recognition and treatment. Early diagnosis and management of endogenous subclinical hyperthyroidism are crucial for preventing cardiovascular complications.
Area of Science:
- Endocrinology
- Thyroidology
- Metabolic Disorders
Background:
- Subclinical hyperthyroidism is defined by suppressed thyroid-stimulating hormone with normal thyroid hormone levels.
- It can be exogenous (L-thyroxine administration) or endogenous (thyroid nodules, goiter, thyroiditis, endemic goiter, elderly).
- Endogenous subclinical hyperthyroidism is controversial regarding treatment and cardiovascular impact, though effects are established.
Discussion:
- Established cardiovascular effects of subclinical hyperthyroidism are demonstrated.
- Recent reports link it to acute myocardial infarction and pulmonary embolism, even without L-thyroxine.
- Prompt recognition and treatment of endogenous subclinical hyperthyroidism are vital.
Key Insights:
- Subclinical hyperthyroidism involves suppressed TSH with normal T4/T3.
- Endogenous forms are linked to various thyroid conditions and demographics.
- Cardiovascular risks, including MI and PE, are associated with this condition.
Outlook:
- Further research is needed to clarify optimal treatment strategies.
- Understanding the cardiovascular implications is essential for patient management.
- Increased awareness and timely intervention can mitigate adverse outcomes.
Related Concept Videos
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:23Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...